Rosmarinic acid prevents fibrillization and diminishes vibrational modes associated to β sheet in tau protein linked to Alzheimer’s disease

References

• Galpern WR, Lang AE. Interface between tauopathies and synucleinopathies: a tale of two proteins. Ann Neurol 2006;59:449–58.
   PubMed Web of Science ®Google Scholar
• Litvan I, Hauw JJ, Bartko JJ, et al. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 1996;55:97–105.
   PubMed Web of Science ®Google Scholar
• Dickson DW, Bergeron C, Chin SS, et al. Office of rare diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 2002;61:935–46.
   PubMed Web of Science ®Google Scholar
• Kadavath H, Hofele RV, Biernat J, et al. Tau stabilizes microtubules by binding at the interface between tubulin heterodimers. Proc Natl Acad Sci USA 2015;112:7501–6.
   PubMed Web of Science ®Google Scholar
• Greenberg SG, Davies PA. A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc Natl Acad Sci USA 1990;87:5827–31.
   PubMed Web of Science ®Google Scholar
• Grundke-Iqbal I, Iqbal K, Tung YC, et al. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 1986;83:4913–7.
   PubMed Web of Science ®Google Scholar
• Ballatore C, Lee VM, Trojanowski JQ. Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders. Nat Rev Neurosci 2007;8:663–72.
   PubMed Web of Science ®Google Scholar
• Sawaya MR, Sambashivan S, Nelson R, et al. Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature 2007;447:453–7.
   PubMed Web of Science ®Google Scholar
• Landau M, Sawaya MR, Faull KF, et al. Towards a pharmacophore for amyloid. PLoS Biol 2011;9:e1001080.
   PubMed Web of Science ®Google Scholar
• Meng SR, Zhu YZ, Guo T, et al. Fibril-forming motifs are essential and sufficient for the fibrillization of human Tau. PLoS One 2012;7:e38903.
   PubMed Web of Science ®Google Scholar
• Plumley JA, Dannenberg JJ. Comparison of β-sheets of capped polyalanine with those of the tau-amyloid structures VQIVYK and VQIINK. A density functional theory study. J Phys Chem B 2011;115:10560–6.
   PubMed Web of Science ®Google Scholar
• Peterson DW, Zhou H, Dahlquist FW, Lew J. A soluble oligomer of tau associated with fiber formation analyzed by NMR. Biochemistry 2008;47:7393–404.
   PubMed Web of Science ®Google Scholar
• Farias G, Cornejo A, Jimenez J, et al. Mechanisms of tau self-aggregation and neurotoxicity. Curr Alzheimer Res 2011;8:608–14.
   PubMed Web of Science ®Google Scholar
• Sahara N, Maeda S, Takashima A. Tau oligomerization: a role for tau aggregation intermediates linked to neurodegeneration. Curr Alzheimer Res 2008;5:591–8.
   PubMed Web of Science ®Google Scholar
• Oddo S, Vasilevko V, Caccamo A, et al. Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles. J Biol Chem 2006;281:39413–23.
   PubMed Web of Science ®Google Scholar
• Khlistunova I, Biernat J, Wang Y, et al. Inducible expression of Tau repeat domain in cell models of tauopathy: aggregation is toxic to cells but can be reversed by inhibitor drugs. J Biol Chem 2006;281:1205–14.
   PubMed Web of Science ®Google Scholar
• Holmes C, Boche D, Wilkinson D, et al. Long-term effects of Abeta42 immunisation in Alzheimer’s disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet 2008;372:216–23.
   PubMed Web of Science ®Google Scholar
• Rinne JO, Brooks DJ, Rossor MN, et al. 11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer’s disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study. Lancet Neurol 2010;9:363–72.
   PubMed Web of Science ®Google Scholar
• Extance A. Alzheimer’s failure raises questions about disease-modifying strategies. Nat Rev Drug Discov 2010;9:749–51.
   PubMed Web of Science ®Google Scholar
• Brunden KR, Trojanowski JQ, Lee VM. Advances in tau-focused drug discovery for Alzheimer’s disease and related tauopathies. Nat Rev Drug Discov 2009;8:783–93.
   PubMed Web of Science ®Google Scholar
• Bulic B, Pickhardt M, Schmidt B, et al. Development of tau aggregation inhibitors for Alzheimer’s disease. Angew Chem Int Ed Engl 2009;48:1740–52.
   PubMed Web of Science ®Google Scholar
• Kim J, Lee HJ, Lee KW. Naturally occurring phytochemicals for the prevention of Alzheimer’s disease. J Neurochem 2010;112:1415–30.
   PubMed Web of Science ®Google Scholar
• Porat Y, Abramowitz A, Gazit E. Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism. Chem Biol Drug Des 2006;67:27–37.
   PubMed Web of Science ®Google Scholar
• Bastianetto S, Krantic S, Quirion R. Polyphenols as potential inhibitors of amyloid aggregation and toxicity: possible significance to Alzheimer’s disease. Mini Rev Med Chem 2008;8:429–35.
   PubMed Web of Science ®Google Scholar
• Carbonaro M, DiVenere A, Filabozzi A, et al. Role of dietary antioxidant (-)-epicatechin in the development of β-lactoglobulin fibrils. Biochim Biophys Acta 2016;1864:766–72.
   PubMed Web of Science ®Google Scholar
• Shytle RD, Tan J, Bickford PC, et al. Optimized turmeric extract reduces β-Amyloid and phosphorylated Tau protein burden in Alzheimer’s transgenic mice. Curr Alzheimer Res 2012;9:500–6.
   PubMed Web of Science ®Google Scholar
• Peterson DW, George RC, Scaramozzino F, et al. Cinnamon extract inhibits tau aggregation associated with Alzheimer’s disease in vitro. J Alzheimers Dis 2009;17:585–97.
   PubMed Web of Science ®Google Scholar
• Cornejo A, Jimenez JM, Caballero L, et al. Fulvic acid inhibits aggregation and promotes disassembly of tau fibrils associated with Alzheimer’s disease. J Alzheimers Dis 2011;27:143–53.
   PubMed Web of Science ®Google Scholar
• Englberger W, Hadding U, Etschenberg E, et al. Rosmarinic acid: a new inhibitor of complement C3-convertase with anti-inflammatory activity. Int J Immunopharmacol 1988;10:729–37.
   PubMed Web of Science ®Google Scholar
• Aruoma OI, Spencer JP, Rossi R, et al. An evaluation of the antioxidant and antiviral action of extracts of rosemary and Provençal herbs. Food Chem Toxicol 1996;34:449–56.
   PubMed Web of Science ®Google Scholar
• Karran E, Mercken M, De Strooper B. The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov 2011;10:698–712.
   PubMed Web of Science ®Google Scholar
• Wischik CM, Harrington CR, Storey JM. Tau-aggregation inhibitor therapy for Alzheimer’s disease. Biochem Pharmacol 2014;88:529–39.
   PubMed Web of Science ®Google Scholar
• Dimayuga RE, Garcia SK, Nielsen PH, Christophersen C. Traditional medicine of Baja California Sur (Mexico). III. Carnosol: a diterpene antibiotic from Lepechinia hastata. J Ethnopharmacol 1991;31:43–8.
   PubMed Web of Science ®Google Scholar
• Wang M, Li J, Rangarajan M, et al. Antioxidative phenolic compounds from Sage (Salvia officinalis). J Agric Food Chem 1998;46:4869–73.
   Web of Science ®Google Scholar
• Schwarz K, Ternes W. Antioxidative constituents of Rosmarinus officinalis and Salvia officinalis. II. Isolation of carnosic acid and formation of other phenolic diterpenes. Z Lebensm Unters Forsch 1992;195:99–103.
   PubMedGoogle Scholar
• Pukalskas A, van Beek TA, de Waard P. Development of a triple hyphenated HPLC-radical scavenging detection-DAD-SPE-NMR system for the rapid identification of antioxidants in complex plant extracts. J Chromatogr A 2005;1074:81–8.
   PubMed Web of Science ®Google Scholar
• Pickhardt M, Gazova Z, von Bergen M, et al. Anthraquinones inhibit tau aggregation and dissolve Alzheimer’s paired helical filaments in vitro and in cells. J Biol Chem 2005;280:3628–35.
   PubMed Web of Science ®Google Scholar
• Crowe A, Ballatore C, Hyde E, et al. High throughput screening for small molecule inhibitors of heparin-induced tau fibril formation. Biochem Biophys Res Commun 2007;358:1–6.
   PubMed Web of Science ®Google Scholar
• Rygula A, Majzner K, Marzec KM, et al. Raman spectroscopy of proteins: a review. J Raman Spectrosc 2013;44:1061–76.
   Web of Science ®Google Scholar
• Jorgensen WL, Schyman P. Treatment of halogen bonding in the OPLS-AA force field; application to potent anti-HIV agents. J Chem Theory Comput 2012;8:3895–01.
   PubMed Web of Science ®Google Scholar
• Eldridge MD, Murray CW, Auton TR, et al. Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes. J Comput Aided Mol Des 1997;11:425–45.
   PubMed Web of Science ®Google Scholar
• Alzate-Morales JH, Vergara-Jaque A, Caballero J. Computational study on the interaction of N1 substituted pyrazole derivatives with B-raf kinase: an unusual water wire hydrogen-bond network and novel interactions at the entrance of the active site. J Chem Inf Model 2010;50:1101–12.
   PubMed Web of Science ®Google Scholar
• Friesner RA, Banks JL, Murphy RB, et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 2004;47:1739–49.
   PubMed Web of Science ®Google Scholar
• Satoh T, McKercher SR, Lipton SA. Nrf2/ARE-mediated antioxidant actions of pro-electrophilic drugs. Free Radic Biol Med 2013;65:645–57.
   PubMed Web of Science ®Google Scholar
• Perez-Fons L, Garzon MT, Micol V. Relationship between the antioxidant capacity and effect of rosemary (Rosmarinus officinalis L.) polyphenols on membrane phospholipid order. J Agric Food Chem 2010;58:161–71.
   PubMed Web of Science ®Google Scholar
• Meng P, Yoshida H, Matsumiya T, et al. Carnosic acid suppresses the production of amyloid-β 1-42 by inducing the metalloprotease gene TACE/ADAM17 in SH-SY5Y human neuroblastoma cells. Neurosci Res 2013;75:94–102.
   PubMed Web of Science ®Google Scholar
• Yoshida H, Meng P, Matsumiya T, et al. Carnosic acid suppresses the production of amyloid-β 1-42 and 1-43 by inducing an α-secretase TACE/ADAM17 in U373MG human astrocytoma cells. Neurosci Res 2014;79:83–93.
   PubMed Web of Science ®Google Scholar
• Johnson JJ. Carnosol: a promising anti-cancer and anti-inflammatory agent. Cancer Lett 2011;305:1–7.
   PubMed Web of Science ®Google Scholar
• Johnson JJ, Syed DN, Suh Y, et al. Disruption of androgen and estrogen receptor activity in prostate cancer by a novel dietary diterpene carnosol: implications for chemoprevention. Cancer Prev Res (Phila) 2010;3:1112–23.
   PubMed Web of Science ®Google Scholar
• Fawcett JR, Bordayo EZ, Jackson K, et al. Inactivation of the human brain muscarinic acetylcholine receptor by oxidative damage catalyzed by a low molecular weight endogenous inhibitor from Alzheimer’s brain is prevented by pyrophosphate analogs, bioflavonoids and other antioxidants. Brain Res 2002;950:10–20.
   PubMed Web of Science ®Google Scholar
• Iuvone T, De Filippis D, Esposito G, et al. The spice sage and its active ingredient rosmarinic acid protect PC12 cells from amyloid-beta peptide-induced neurotoxicity. J Pharmacol Exp Ther 2006;317:1143–9.
   PubMed Web of Science ®Google Scholar
• Hamaguchi T, Ono K, Murase A, Yamada M. Phenolic compounds prevent Alzheimer’s pathology through different effects on the amyloid-beta aggregation pathway. Am J Pathol 2009;175:2557–65.
   PubMed Web of Science ®Google Scholar
• Levine H. Thioflavine-T interaction with synthetic Alzheimers-disease beta-amyloid peptides – detection of amyloid aggregation in solution. Protein Science 1993;2:404–10.
   PubMed Web of Science ®Google Scholar
• Di Giovanni S, Eleuteri S, Paleologou KE, et al. Entacapone and tolcapone, two catechol O-methyltransferase inhibitors, block fibril formation of alpha-synuclein and beta-amyloid and protect against amyloid-induced toxicity. J Biol Chem 2010;285:14941–54.
   PubMed Web of Science ®Google Scholar
• Mohamed T, Hoang T, Jelokhani-Niaraki M, Rao PP. Tau-derived-hexapeptide 306VQIVYK311 aggregation inhibitors: nitrocatechol moiety as a pharmacophore in drug design. ACS Chem Neurosci 2013;4:1559–70.
   PubMed Web of Science ®Google Scholar
• Barghorn S, Zheng-Fischhofer Q, Ackmann M, et al. Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias. Biochemistry 2000;39:11714–21.
   PubMed Web of Science ®Google Scholar
• Ramachandran G, Milan-Garces EA, Udgaonkar JB, Puranik M. Resonance Raman spectroscopic measurements delineate the structural changes that occur during tau fibril formation. Biochemistry 2014;53:6550–65.
   PubMed Web of Science ®Google Scholar
• Wen ZQ. Raman spectroscopy of protein pharmaceuticals. J Pharm Sci 2007;96:2861–78.
   PubMed Web of Science ®Google Scholar
• Krimm S, Bandekar J. Vibrational spectroscopy and conformation of peptides, polypeptides, and proteins. Adv Protein Chem 1986;38:181–364.
   PubMedGoogle Scholar
• Maiti NC, Apetri MM, Zagorski MG, et al., Raman spectroscopic characterization of secondary structure in natively unfolded proteins: alpha-synuclein. J Am Chem Soc 2004;126:2399–408.
   PubMed Web of Science ®Google Scholar
• Cornejo A, Salgado F, Caballero J, et al. Secondary metabolites in Ramalina terebrata detected by UHPLC/ESI/MS/MS and identification of parietin as tau protein inhibitor. Int J Mol Sci 2016;17:E1303. doi: 10.3390/ijms17081303
   PubMed Web of Science ®Google Scholar